Afex (2.5+4+10) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Eden Healthcare. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Bromhexine, Guaiphenesin IP,Terbutaline Sulphate. This drug comes in the form of Tablet. The general packing available for this medicine consists of 200 Tablet and is priced at Rs 150 (arround $2.1 US Dollar)
The main active ingredients or salts in Afex (2.5+4+10) are :
Bromhexine-4 mg
Terbutaline Sulphate-2.5 mg
Guaiphenesin IP-10 mg
Bromhexine Indication (Prescribed for or used as): Potent mucolytic and mucokinetic agent, capable of bringing out bronchial secretion especially mucous plugs. Chronic obstructive lung disease and bronchiectisis.
For more details on Bromhexine, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Bromhexine..
Guaiphenesin IP Indication (Prescribed for or used as):
For more details on Guaiphenesin IP, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Guaiphenesin IP..
Terbutaline Sulphate Indication (Prescribed for or used as): Reversible airway obstructive diseases. Uncomplicated premature labor.
For more details on Terbutaline Sulphate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Terbutaline Sulphate..
Afex (2.5+4+10) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 0 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Afex (2.5+4+10), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Bromhexine-4 mg Terbutaline Sulphate-2.5 mg Guaiphenesin IP-10 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.